Form 4 for G Genpact LTD
Accepted 2023-05-08 00:00:00 ET · period of report 2023-05-04 · accession 0001140361-23-023501 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-08 | 2023-05-04 | G | Morken CeCelia | Dir | A - Grant | $0.00 | +4,916 | 41.2K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-05-04 | A | A | 4,916 | $0.00 | 41,228 | D | — | — | (F1) Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024. |